Online Exclusive Article

Searching for a Way to Live to the End: Decision-Making Process in Patients Considering Participation in Cancer Phase I Clinical Trials

Izumi Kohara

Tomoko Inoue

decision making, clinical trials
ONF 2010, 37(2), E124-E132. DOI: 10.1188/10.ONF.E124-E132

Purpose/Objectives: To reveal the decision-making process in patients considering participation in cancer phase I clinical trials.

Design: Grounded theory approach.

Setting: Cancer center in a metropolitan area of Tokyo, Japan.

Participants: 25 patients with cancer, including individuals who ultimately declined to participate in a phase I trial.

Methodologic Approach: Semistructured interviews and unstructured observations were conducted.

Main Research Variables: Patients' decision-making process and influencing factors.

Findings: The core category of patients' decision-making process was searching for a way to live to the end. The process consisted of four phases: only waiting for death to come if nothing is done, assessing the value of the phase I trial, finding decisive factors, and reminding oneself that this is the right decision. Factors influencing the process included patients' perceptions of physicians' explanations of the phase I trial, patients' perceptions of their families' attitudes toward the phase I trial, patients' experiences with past anticancer therapies, and patients' attitudes toward living with cancer.

Conclusions: Patient decision-making is a challenging process associated with issues about how to live at the end of life. The pattern of searching for a way to live to the end differed depending on the levels of the four factors that influenced patients' decision-making process.

Implications for Nursing: Nurses play pivotal roles in talking to patients about phase I trials, discussing what is important for the rest of their lives, and recognizing that patients made a satisfying decision for themselves.

Jump to a section

    References

    Aaronson, N. K., Visser-Pol, E., Leenhouts, G. H., Muller, M. J., Astrid, C. M., Schot, V. D., … Dubbelman, R. (1996). Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. Journal of Clinical Oncology, 14, 984-996.
    Agrawal, M., & Danis, M. (2002). End-of-life care for terminally ill participants in clinical research. Journal of Palliative Medicine, 5, 729-737. doi: 10.1089/109662102320880552
    Agrawal, M., & Emanuel, E. J. (2003). Ethics of phase I oncology studies: Reexamining the arguments and data. JAMA, 290, 1075-1082. doi: 10.1001/jama.290.8.1075
    Agrawal, M., Grady, C. L., Fairclough, D. J., Meropol, N., Maynard, K. J., & Emanuel, E. J. (2006). Patients' decision-making process regarding participation in phase I oncology research. Journal of Clinical Oncology, 24, 4479-4484. doi: 10.1200/JCO.2006.06.0269
    Appelbaum, P. S., & Grisso, T. (1988). Assessment of patients' capacities to consent to treatment. New England Journal of Medicine, 319, 1635-1638.
    Bachelot, T., Ray-Coquard, I., Catimel, G., Ardiet, C., Guastalla, J. P., Dumortier, A., … Clavel, M. (2000). Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials. Annals of Oncology, 11, 151-156.
    Barrett, R. (2005). Quality of informed consent: Measuring understanding among participants in oncology clinical trials. Oncology Nursing Forum, 32, 751-755. doi: 10.1188/05.ONF.751-755
    Cheng, J. D., Hitt, J., Koczwara, B., Schulman, K. A., Burnett, C. B., Gaskin, D. J., … Meropol, N. J. (2000). Impact of quality of life on patient expectations regarding phase I clinical trials. Journal of Clinical Oncology, 18, 421-428.
    Cox, K. (2000). Enhancing cancer clinical trial management: Recommendations from a qualitative study of trial participants' experiences. Psycho-Oncology, 9, 314-32.
    Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., & Siegler, M. (1995). Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology, 13, 1062-1072.
    Flory, J., & Emanuel, E. (2004). Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA, 292, 1593-1601. doi: 10.1001/jama.292.13.1593
    Han, C., Braybrooke, J., Deplanque, G., Taylor, M., Mackintosh, D., Kaur, K., … Talbot, D. C. (2003). Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs versus new noncytotoxic agents. British Journal of Cancer, 89, 1166-1171. doi: 10.1038/sj.bjc.6601218
    Horng, S., Emanuel, E. J., Wilfond, B., Rackoff, J., Martz, K., & Grady, C. (2002). Descriptions of benefits and risks in consent forms for phase 1 oncology trials. New England Journal of Medicine, 347, 2134-2140. doi: 10.1056/NEJMsa021182
    Horstmann, E., McCabe, M. S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, T., … Grady, C. (2005). Risks and benefits of phase I oncology trials, 1991 through 2002. New England Journal of Medicine, 352, 895-904. doi: 10.1056/NEJMsa042220
    Itoh, K., Sasaki, Y., Fujii, H., Ohtsu, T., Wakita, H., Igarashi, T., & Abe, K. (1997). Patients in phase I trials of anticancer agents in Japan: Motivation, comprehension and expectations. British Journal of Cancer, 76, 107-113.
    Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001). Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet, 358(9295), 1772-1777. doi: 10.1016/S0140-6736(01)06805-2
    Lengacher, C. A., Gonzalez, L., Giuliano, R., Bennett, M. P., Cox, C. E., & Reintgen, D. S. (2001). The process of clinical trials: A model for successful clinical trial participation. Oncology Nursing Forum, 28, 1115-1120.
    Madsen, S. M., Holm, S., & Riis, P. (2007). Participating in a cancer clinical trial? The balancing of options in the loneliness of autonomy: A grounded theory interview study. Acta Oncologica, 46, 49-59.
    Meropol, N. J., Weinfurt, K. P., Burnett, C. B., Balshem, A., Benson, A. B., Castel, L., … Schulman, K. A. (2003). Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. Journal of Clinical Oncology, 21, 2589-2596. doi: 10.1200/JCO.2003.10.072
    Moore, S. (2001). A need to try everything: Patient participation in phase I trials. Journal of Advanced Nursing, 33, 738-747.
    Nurgat, Z., Craig, W., Campbell, N., Bissett, J., Cassidy, J., & Nicolson, M. (2005). Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. British Journal of Cancer, 92, 1001-1005. doi: 10.1038/sj.bjc.6602423
    Pierce, P. F., & Hicks, F. D. (2001). Patient decision-making behavior: An emerging paradigm for nursing science. Nursing Research, 50, 267-274.
    Schaefer, K. M., Ladd, E., Gergits, M. A., & Gyauch, L. (2001). Backing and forthing: The process of decision making by women considering participation in a breast cancer prevention trial. Oncology Nursing Forum, 28, 703-709.
    Schutta, K. M., & Burnett, C. B. (2000). Factors that influence a patient's decision to participate in a phase I cancer clinical trial. Oncology Nursing Forum, 27, 1435-1438.
    Strauss, A. L., & Corbin, J. M. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.
    Yoder, L. H., O'Rourke, T. J., Etnyre, A., Spears, D. T., & Brown, T. D. (1997). Expectations and experiences of patients with cancer participating in phase I clinical trials. Oncology Nursing Forum, 24, 891-896.